drug

(hyaluronidase (human recombinant) + ocrelizumab)

Marketedupdated 3mo ago

by Genentech Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying (hyaluronidase (human recombinant) + ocrelizumab)

—Ocrevus Zunovo for MS: Mixed Methodsrecruitingn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed just now

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

(hyaluronidase (human recombinant) + ocrelizumab)

Marketedupdated 3mo ago

by Genentech Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying (hyaluronidase (human recombinant) + ocrelizumab)

—Ocrevus Zunovo for MS: Mixed Methodsrecruitingn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed just now

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

(hyaluronidase (human recombinant) + ocrelizumab)

all catalysts(0)

Trials studying (hyaluronidase (human recombinant) + ocrelizumab)

News(0)

Report a data issue

comments(0)

(hyaluronidase (human recombinant) + ocrelizumab)

all catalysts(0)

Trials studying (hyaluronidase (human recombinant) + ocrelizumab)

News(0)

Report a data issue

comments(0)